Rishi Pandya

Rishi Pandya practices at Saint Mary of Nazareth Hospital in Chicago, Illinois, part of Prime Healthcare Services.

Rishi Pandya's NPI, 1043699275, was assigned on May 20, 2015. Rishi Pandya graduated from University of Chicago, Pritzker School of Medicine in 2015. Rishi Pandya holds Illinois license 036150193.

Rishi Pandya's primary practice is Saint Mary of Nazareth Hospital, at 2233 W Division St, Chicago, IL 60622 in Cook County. The practice phone is (312) 770-2000.

Rishi Pandya's primary practice is Saint Mary of Nazareth Hospital in Chicago, Illinois, part of Prime Healthcare Services. Rishi Pandya is also affiliated with Resurrection Medical Center. The medical group on file is Prime Healthcare Illinois Medical Group. Dmand AI also links Rishi Pandya to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rishi Pandya practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Rishi Pandya's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Rishi Pandya is licensed in Illinois.

CMS data shows 2,025 Medicare services from Rishi Pandya across 12 procedure codes in 2024, for 986 Medicare patients. Medicare paid $88,313 for them.

CMS counts 986 Medicare patients who saw Rishi Pandya in 2024. The largest group is 75 to 84, with 359 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 60% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rishi Pandya's median patient age at 69, with 49% women.

In 2024, Rishi Pandya wrote 755 Medicare Part D claims for 187 patients. 71% of them were for generic drugs. CMS names the drug for 628 of them, across 14 drugs with 11 or more claims each, at $243,372 in total drug cost. In 2023, CMS named 239 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Rishi Pandya for performance year 2024, reported as part of a group. Rishi Pandya accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Rishi Pandya, published from 2019 to 2023. Rishi Pandya has published most often in Br J Oral Maxillofac Surg. Rishi Pandya's most frequent co-authors are Ahmed Khaled Abdelaziz Abdelrahman, Jonathan S. Austrian, MD and Saul Bryan Blecker, MD.

CMS Open Payments shows 234 general payments to Rishi Pandya from 32 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 39% of the total. Medtronic, Inc. paid the most, $11,973.

Rishi Pandya graduated from University of Chicago, Pritzker School of Medicine in 2015.